Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion

The susceptibility of Escherichia coli B to the antibacterial activity of silver ions was measured in terms of the initial inhibitory concentration, complete inhibitory concentration, postagent effect for bacteriostatic susceptibility, minimum bactericidal concentration, maximum tolerant concentration, and log killing time for bactericidal activity. At a concentration of 9.45 μM and an inoculum size of 10 CFU ml, silver caused growth delay of E. coli; at a concentration of 18.90 μM, silver completely inhibited bacterial growth. Prolonged postagent effects ranged between 1.5 and 12 h at 0.75 x the initial inhibitory concentration, 1.0 x the initial inhibitory concentration, and 1.5 x the initial inhibitory concentration of the silver ion. One log-unit of viable bacterial population size was lost every 30 min at the minimum bactericidal concentration of the silver ion. Silver tolerance was determined as 20 times the initial inhibitory concentration with 48 h of exposure. This study presents an evaluative model as a reference for the quantitative analysis of the susceptibility of bacteria to silver ions. © Rapid Science 1998.

[1]  Andrew A. Marino,et al.  Silver-nylon: a new antimicrobial agent , 1983, Antimicrobial Agents and Chemotherapy.

[2]  EuropeanCommittee forAntimicrobial SusceptibilityTesting EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  D. Long Silver nitrate therapy as an adjunct in the treatment of myelomeningocele. , 1972, Journal of neurosurgery.

[4]  R. Ersek,et al.  Cross-linked silver-impregnated skin for burn wound management. , 1988, The Journal of burn care & rehabilitation.

[5]  S. Shah,et al.  Silver sulphadiazine: a comprehensive in vitro reassessment. , 1993, Chemotherapy.

[6]  S Person,et al.  Silver-coated nylon fiber as an antibacterial agent , 1987, Antimicrobial Agents and Chemotherapy.

[7]  C. L. Fox Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. , 1968, Archives of surgery.

[8]  S. Modak,et al.  Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. , 1973, Biochemical pharmacology.

[9]  R. Becker,et al.  Treatment of orthopaedic infections with electrically generated silver ions. A preliminary report. , 1978, The Journal of bone and joint surgery. American volume.

[10]  R O Becker,et al.  Electrically Generated Silver Ions: Quantitative Effects on Bacterial and Mammalian Cells , 1976, Antimicrobial Agents and Chemotherapy.

[11]  R. Becker,et al.  Antifungal Properties of Electrically Generated Metallic Ions , 1976, Antimicrobial Agents and Chemotherapy.

[12]  S. Handelman,et al.  Inhibition and Killing of Oral Bacteria by Silver Ions Generated with Low Intensity Direct Current , 1978, Journal of dental research.

[13]  O. Cars,et al.  Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin , 1992, Antimicrobial Agents and Chemotherapy.

[14]  R. Tauxe,et al.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.

[15]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[16]  N. Grier Silver and its compounds , 1977 .

[17]  A. Harden Bacterial Metabolism , 1930, Nature.

[18]  J. Trevors,et al.  Bacterial interactions with silver , 2005, Biology of Metals.

[19]  A. Tomasz,et al.  Antibiotic tolerance among clinical isolates of bacteria , 1986, Antimicrobial Agents and Chemotherapy.

[20]  J. Karlowsky,et al.  Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli , 1992, Antimicrobial Agents and Chemotherapy.

[21]  K. Gadre,et al.  Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate , 1992, The Journal of Laryngology & Otology.

[22]  M. Laverdière,et al.  A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS , 1977, The Lancet.